Jim Wassil - Mar 2, 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role: Chief Operating Officer
Signature: /s/ Ron Metzger, Attorney-in-Fact
Stock symbol: PCVX
Transactions as of: Mar 2, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/4/2022, 07:58 PM
Previous filing: Feb 28, 2022
Next filing: Apr 20, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCVX	Common Stock	Award	$0	+25K	+139.32%	$0.00	42.9K	Mar 2, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCVX	Stock Option (right to buy)	Award	$0	+100K		$0.00	100K	Mar 2, 2022	Common Stock	100K	$24.79	Direct	F2
transaction	PCVX	Stock Option (right to buy)	Award	$0	+150K		$0.00	150K	Mar 2, 2022	Common Stock	150K	$24.79	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 2, 2022 and 12.5% of the shares every six months thereafter.
F2	12/48 of shares subject to the option vest on February 15, 2023, and 1/48 of the shares vest monthly thereafter.
F3	1/48 of shares subject to the option vest on April 2, 2022, and 1/48 of the shares vest monthly thereafter.